AME - Ametek Inc
Executive Summary
Ametek Inc (NYSE: AME) is a US-listed manufacturer of electronic instruments and electromechanical devices, organised across two segments - Electronic Instruments (EIG) and Electromechanical (EMG) - serving process, aerospace, defence, medical, energy, and industrial customers worldwide. The group has built its scale through a sustained programme of bolt-on acquisitions layered on top of steady organic growth, and currently sits close to its 52-week high with a market profile of a high-quality diversified industrial.
The investment case rests on three near-term execution items: the closing of the previously announced USD5bn Indicor instrumentation acquisition in the second half of 2026, the delivery of full-year 2026 EPS guidance of USD7.94 - 8.14 against Q2 guidance of USD1.96 - 2.00 per share, and continued organic growth in the mid-single-digit range. The principal risk is that international demand - 48% of sales are outside the United States - weakens on foreign economic or political disruption, materially compressing margins and forcing a re-rating lower.
OPPORTUNISTIC BUY. Conviction Score: 61/100. The view would upgrade to a higher tier on clean Indicor close and confirmed synergy delivery, and would downgrade if any 10-K disclosure of cyclical end-market weakness begins to show in quarterly organic growth prints.
Thesis break: A confirmed Indicor close materially off the announced USD5bn economics (price, structure, or timing), or two consecutive quarters of organic growth printing below mid-single digits, would invalidate the thesis regardless of price.
Business Model
Ametek generates revenue by designing and manufacturing highly engineered products across two reporting segments. The Electronic Instruments Group supplies analytical, monitoring, and test instrumentation to process, aerospace, medical, and laboratory end markets, while the Electromechanical Group produces precision motion control, specialty metals, and interconnects used in industrial automation, defence, and commercial applications. Pricing is largely specification-driven rather than commodity, with most products sold into regulated or technical niches where Ametek's brand, application know-how, and aftermarket service are difficult to replicate.
Customers are industrial OEMs, aerospace and defence primes, hospitals and laboratories, energy operators, and a long tail of process manufacturers. A meaningful share of revenue is recurring or aftermarket in character - spares, services, and consumables tied to an installed base - which underpins the group's resilience relative to a pure cyclical industrial. Ametek's competitive moat is built less on a single product and more on a repeatable playbook: decentralised operating model, premium pricing on engineered content, and the disciplined use of free cash flow to fund roughly five to ten bolt-on acquisitions per year in fragmented niche markets.
The group's profitability profile is structurally above the broader electrical equipment peer set, reflecting the mix-shift towards higher-margin instrumentation over time and the operating leverage generated by the acquisition programme. Reported P/E of 37.08x at the current price of USD253.66 already prices in much of the growth and margin trajectory, which is the principal reason the recommendation stops at OPPORTUNISTIC BUY rather than moving higher.
Financial Snapshot
Recent Catalysts
[2026-08-04] - Ametek filed a Form 8-K with the SEC, dated August 4, 2026, associated with an investor communication exhibit covering its most recent reporting period. Source: SEC EDGAR Form 8-K filing (ame-20260804).
[2026-05-01] - Ametek announced full-year 2026 EPS guidance of USD7.94 - 8.14 and second-quarter 2026 EPS guidance of USD1.96 - 2.00 per share, framed around record first-half results. Source: AMETEK press release / company investor relations communication.
[2026-04-30] - Ametek issued an update to its second-quarter 2026 earnings guidance, reaffirming the USD1.96 - 2.00 EPS range. Source: MarketBeat (public wire summary of company guidance).
[Q2 2026] - Ametek announced a definitive agreement to acquire a portfolio of instrumentation businesses (the Indicor portfolio) from Clayton, Dubilier & Rice for approximately USD5bn, with closing expected in the second half of 2026 subject to customary approvals. Source: AMETEK press release on PR Newswire and AMETEK investor relations newsroom; Clayton Dubilier & Rice press release.
[2026-08-09 reference] - At the date of this report, no confirmed Q3 2026 earnings release date has been verified from the research data provided; the next scheduled catalyst not already dated is the closing of the Indicor transaction in H2 2026. Source: SEC Form 8-K and AMETEK press releases (Indicor transaction).
Thesis Evaluation
Bull Case (26% weight)
Indicor closes on schedule in H2 2026, the full-year 2026 EPS reaches the upper end of the USD7.94 - 8.14 range, and synergy capture plus continued mid-single-digit organic growth drive a re-rating. Multiple expansion combined with earnings power delivers a 12-month target of $295.
Base Case (53% weight)
Indicor closes in H2 2026 broadly on disclosed terms, FY 2026 EPS lands within the guided USD7.94 - 8.14 corridor, and organic growth tracks the mid-single-digit trajectory consistent with prior quarters. The valuation re-rates only modestly from a P/E of 37.08x, leaving a 12-month target of $268.
Bear Case (21% weight)
International demand softens on the foreign economic and political exposures disclosed in the 10-K, organic growth slips below mid-single digits, and integration friction or financing pressure from the USD5bn Indicor deal compresses margins. A re-rating to a lower peer multiple alongside earnings disappointment drives a 12-month target of $205.
Key Risks
- International sales exposure: Approximately 48% of Ametek's sales are generated outside the United States, leaving earnings exposed to foreign economic weakness, currency translation, and political disruption. Estimated probability: 35%. Impact: moderate.
- Cyclical end-market downturn: Ametek's process, industrial, and aerospace end markets are cyclical and a downturn in capex spend could compress organic growth below the historical mid-single-digit range. Estimated probability: 25%. Impact: severe.
- Indicor integration and financing risk: The USD5bn Indicor acquisition is the largest in Ametek's recent history and integration friction, synergy shortfall, or higher-than-expected financing costs could weigh on margins and free cash flow. Estimated probability: 30%. Impact: moderate.
- Valuation re-rating: The current P/E of 37.08x already prices in continued execution and any disappointment on growth, margins, or guidance could trigger a multiple compression independent of earnings moves. Estimated probability: 30%. Impact: moderate.
Who Should Own It / Avoid It
Ideal for: long-term, quality-oriented industrial investors with a minimum holding period of three to five years, a moderate-to-high risk tolerance, and an explicit preference for compounders that combine organic growth with a disciplined bolt-on M&A programme. The position suits portfolios seeking US-listed industrial diversification with international exposure, and investors comfortable paying a premium multiple for track record rather than a deep value entry.
Avoid if: investors cannot tolerate a forward P/E of 37.08x and would be forced sellers on any multiple de-rating, or those with a mandate restricted to deep-value, low-multiple industrials. Short-term traders should also avoid the name, as the OPPORTUNISTIC BUY thesis depends on multi-year Indicor integration and continued organic execution rather than near-term event-driven moves.
Recommendation
OPPORTUNISTIC BUY - 61/100. The tier reflects a high-quality industrial with visible near-term catalysts and a credible M&A-led growth model, offset by an already-elevated multiple and acknowledged cyclical and international risks in the 10-K. The call would upgrade on a clean Indicor close with disclosed synergy targets intact and on confirmed FY 2026 EPS delivery at or above the upper end of guidance. It would downgrade on any quarterly organic growth print below mid-single digits, on a guidance cut, or on material Indicor integration or financing headwinds. At the current price of $253.66 the shares trade above our buy ceiling of $226.00: the thesis is credible but the price is not - new positions only below that level.
The probability-weighted value across our three scenarios is $261.79, 3% above the current price of $253.66 - the market has not yet priced our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.
below $226.00 - below this level the upside to the base-case target ($268.00) is at least 2x the downside to the bear case ($205.00), the minimum risk/reward we require before committing new capital.
between $226.00 and $268.00 - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.
above $268.00 - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 26%.
if A confirmed Indicor close materially off the announced USD5bn economics (price, structure, or timing), or two consecutive quarters of organic growth printing below mid-single digits, would invalidate the thesis regardless of price, regardless of price - the bear target of $205.00 is the backstop, not an arbitrary percentage stop.
Conviction Trend
Latest conviction: 61/100. Trend versus prior report: Down.
| Report date | Conviction |
|---|---|
| 2026-08-09 | 61 |
| 2026-07-25 | 64 |
| 2026-06-28 | 53 |
| 2026-05-30 | 60 |
| 2026-04-28 | 80 |
Sources
Market data: DYOR HQ proprietary market data workflow.
Public sentiment and news flow: Public news flow drawn from company press releases (AMETEK investor relations newsroom, PR Newswire), regulatory filings (SEC EDGAR 8-K and 10-K), Clayton Dubilier & Rice press communications on the Indicor transaction, and aggregator commentary on guidance updates and 52-week price action.
Primary source types: SEC filings (Form 8-K dated 2026-08-04, Form 10-K filed 2026-02-17), company press releases and investor relations materials, regulatory announcements, third-party financial news wires summarising company guidance, and the sell-side / private equity counterparty disclosure on the Indicor portfolio transaction.
Key sources
- Quarterly Results - Ametek, Inc.
- Events & Presentations - Ametek, Inc.
- News | Ametek, Inc.
- AME AMETEK, Inc. - Yahoo Finance
- AMETEK, Inc. (AME) Stock Price, Quote, News & Analysis
- AMETEK Announces Record First Quarter 2026 Results and Raises ...
- AMETEK Announces Record First Quarter 2026 Results and Raises ...
- AMETEK Announces Agreement to Acquire First Aviation Services
- AMETEK Announces Agreement to Acquire Indicor Instrumentation
- AMETEK Completes Acquisition of FARO Technologies
Data correct as of 2026-08-09